Dyspepsia: Initial Evaluation and Treatment Guidelines
In patients under 55 years without alarm features, implement H. pylori test-and-treat as first-line management; for those ≥55 years with dyspepsia and weight loss, or any patient with alarm symptoms, refer for urgent endoscopy within 2 weeks. 1, 2, 3
Initial Risk Stratification
The critical first step is identifying patients requiring urgent endoscopy versus those suitable for empirical management. Most patients (approximately 80%) will ultimately have functional dyspepsia after investigation, making a positive diagnosis without endoscopy appropriate in low-risk cases. 1, 4
Alarm Features Requiring Urgent Endoscopy
Refer immediately for 2-week wait endoscopy if: 1, 2
- Age ≥55 years with dyspepsia AND weight loss 1, 2
- Dysphagia (difficulty swallowing at any level) 2, 4
- Hematemesis (vomiting blood) 2, 4
- Persistent vomiting 2, 4
- Age >40 years from high gastric cancer risk areas OR family history of gastro-esophageal malignancy 1, 2
Consider urgent CT scan for: 1
- Age ≥60 years with abdominal pain AND weight loss 1
Consider non-urgent endoscopy for: 1
- Treatment-resistant dyspepsia in patients ≥55 years 1
Critical pitfall: Do not assume all dyspepsia is functional in patients ≥55 years—approximately 20% will have organic disease including gastric cancer. 3
Baseline Investigations
Before initiating treatment, obtain: 1, 3
- Full blood count in all patients aged ≥55 years 1
- Coeliac serology in patients with overlapping IBS-type symptoms (diarrhea, constipation, altered bowel habits) 1, 3
- H. pylori testing via urea breath test (¹³C) or stool antigen test (both >90% sensitivity and specificity) 3
Critical pitfall: Avoid empirical H. pylori eradication without testing—this causes considerable overtreatment and is not recommended. 3
Management Algorithm for Patients Without Alarm Features
Step 1: H. pylori Test-and-Treat Strategy
For patients <55 years without alarm features: 1, 3, 4
If H. pylori positive: 3
- Prescribe bismuth quadruple therapy or concomitant therapy (preferred due to clarithromycin resistance) 3
- Standard triple therapy: Omeprazole 20 mg + Amoxicillin 1000 mg + Clarithromycin 500 mg, all twice daily for 10 days 5
- If ulcer present at initiation, continue omeprazole 20 mg once daily for additional 18 days for ulcer healing 5
If H. pylori negative or symptoms persist after successful eradication: 3
- Proceed to Step 2 (empirical PPI therapy) 3
Step 2: Empirical Acid Suppression
Prescribe omeprazole 20 mg once daily for 4-8 weeks, taken 30-60 minutes before breakfast for optimal acid suppression. 3, 5
- For active duodenal ulcer: 20 mg once daily for 4 weeks (most heal within 4 weeks; some require additional 4 weeks) 5
- For active gastric ulcer: 40 mg once daily for 4-8 weeks 5
- For symptomatic GERD: 20 mg once daily for up to 4 weeks 5
If symptoms resolve: 5
- Stop treatment after 4-8 weeks 5
- If symptoms recur, another course of the same treatment is justified 5
If symptoms persist after 4-8 weeks: 1, 3
- Consider changing drug class or dosing for 2-4 additional weeks 6
- If still no response, refer for endoscopy (though yield is low; decision based on clinical judgment) 6
Critical pitfall: Perform endoscopy off antisecretory therapy (minimum 1 month) when symptoms are present to avoid missing pathology. 3
Making a Positive Diagnosis of Functional Dyspepsia
In the absence of alarm symptoms, diagnose functional dyspepsia when bothersome epigastric pain or burning, early satiation, and/or postprandial fullness persist for >8 weeks. 1, 4
Essential Patient Education
Establish an empathic doctor-patient relationship and explain functional dyspepsia as a disorder of gut-brain interaction. This reduces healthcare utilization and improves quality of life. 1
Discuss with patients: 1
- The chronic, fluctuating nature of the condition 4
- Common symptom triggers (diet, stress, emotional responses) 1
- The gut-brain axis and how it is impacted by cognitive, behavioral, and emotional responses 1
- Postinfective changes that can contribute to symptoms 1
Age-Specific Cutoffs by Region
The age threshold for endoscopy varies by gastric cancer prevalence: 3
- High-risk areas (East Asia, Eastern Europe, South America): Age ≥40 years 3
- Western countries (North America, Western Europe): Age ≥50-55 years 3
Common Pitfalls to Avoid
- Do not routinely order gastric emptying testing or 24-hour pH monitoring in typical functional dyspepsia—these have low diagnostic yield and delay appropriate treatment 2
- Do not rely on symptom subtyping (pain vs. fullness) to predict underlying pathology in uninvestigated dyspepsia—overlap is too significant 3
- Do not overlook celiac disease in patients with overlapping IBS symptoms—it represents a treatable organic cause significantly impacting quality of life 2, 3
- Consider NSAID use carefully—the combination of H. pylori infection and NSAIDs increases bleeding ulcer risk 3
- Antacids may be used concomitantly with omeprazole without reducing efficacy 5